Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Efficient Biosynthesis of Natural Potent Anti-Malarial Drug (Yissum)


總結

Artemisinins, produced from the traditional Chinese medicinal herb Artemisia annua (sweet wormwood), are the only class of drugs against malaria to which there is no known resistance.
However, artemisinin levels in A. annua usually constitute only about 0.01% to 1% of the total dry weight of the plant, and since complete chemical synthesis of artemisinin is complex and inefficient, the drug is too expensive for most malaria sufferers in developing countries and is in short supply worldwide.
The World Health Organisation promotes the use of artemisinin for malaria treatment and has been heavily involved in aiding in the development of artemisinin-based anti-malaria drugs.Only demonstration of artemisinin production outside of host organism.
Authentic artemisinin accumulated in the engineered plants.
Genetically engineered tobacco is easily cultivated.
Efficient, low-cost system for producing artemisinin.


技術優勢

Globally, 247 million clinical episodes of malaria are estimated to occur every year
Artemisinin-based combination therapy (ACT) has been recommended by WHO since 2001 as the first-line treatment for uncomplicated malaria


申請號碼

United States patent filed (61/486,546


ID號碼

6-2008-2099


國家/地區

以色列

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版